Hottub News

HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer

3 reports from 3 outlets in 1 language · first reported · updated · JSON

HealthHutchison MediPharma LimitedUnited States Food and Drug AdministrationTagrissoEGFR

Reports

  1. HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung CancerPublished by manilatimes.net, GlobeNewswire — public companies ·
  2. HUTCHMED Seeks FDA Approval For ORPATHYS-TAGRISSO In Resistant Lung Cancerrttnews.com · en ·

More in Health

  1. After Covid: Life expectancy has almost recovered50 outlets
  2. Doctors warn about the risks energy drinks pose to kids. What families need to know74 outlets
  3. Cat food investigation finds heavy metals, pesticides and plastic chemicals37 outlets
  4. Democratic Republic of Congo: More than 4,000 people in the DR Congo have died from Ebola65 outlets
  5. Plague in Russia? Woman died, 200 people in quarantine23 outlets
  6. Synthetic bee silk set to take sting out of wounds43 outlets